diltiazem has been researched along with Hibernation, Myocardial in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| del Valle, HF; Lascano, EC; Negroni, JA | 1 |
| Barbosa, V; Buser, PT; Lee, RJ; Zaugg, CE; Ziegler, A | 1 |
| Kirby, DS; Lobato, EB; Muehlschlegel, JD; Muehschlegel, JD; Sidi, A | 1 |
| Abdelmeguid, AE; Feher, JJ | 1 |
| Gurbel, PA; Herzog, WR; Serebruany, VL | 2 |
| Haruna, M; Hirono, S; Ishii, M; Iwaki, K; Kimoto, S; Matsuura, E; Ueda, M; Uno, O; Yoshimura, K | 1 |
| Gurbel, PA; Herzog, WR; Serebruany, VL; Solomon, SR | 1 |
| Edenbaum, LR; Gurbel, PA; Herzog, WR; Schlossberg, ML; Serebruany, VL | 1 |
9 other study(ies) available for diltiazem and Hibernation, Myocardial
| Article | Year |
|---|---|
Ischemic shortening of action potential duration as a result of KATP channel opening attenuates myocardial stunning by reducing calcium influx.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Glyburide; Ischemia; Ischemic Preconditioning, Myocardial; Male; Myocardial Stunning; Pericardium; Potassium Channels; Reperfusion Injury; Sheep; Time Factors | 2002 |
Postresuscitation stunning: postfibrillatory myocardial dysfunction caused by reduced myofilament Ca2+ responsiveness after ventricular fibrillation-induced myocyte Ca2+ overload.
Topics: Actin Cytoskeleton; Animals; Blood Flow Velocity; Calcium Channel Blockers; Calcium Channels; Cardiopulmonary Resuscitation; Coronary Vessels; Diltiazem; Disease Models, Animal; Electric Countershock; Electrophysiologic Techniques, Cardiac; Heart Rate; Hydrogen-Ion Concentration; Male; Models, Cardiovascular; Myocardial Contraction; Myocardial Stunning; Myocardium; Myocytes, Cardiac; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Treatment Failure; Ventricular Fibrillation; Ventricular Pressure | 2002 |
Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs.
Topics: Analysis of Variance; Animals; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Diltiazem; Disease Models, Animal; Heart Rate; Lactic Acid; Milrinone; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Phosphodiesterase Inhibitors; Research Design; Swine; Time Factors; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure | 2007 |
Effect of low perfusate [Ca2+] and diltiazem on cardiac sarcoplasmic reticulum in myocardial stunning.
Topics: Animals; Calcium; Diltiazem; Heart; Kinetics; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Time Factors | 1994 |
Serial changes of natural antithrombotics during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitor.
Topics: Animals; Antithrombins; Diltiazem; Heart; Macrophage-1 Antigen; Magnesium; Myocardial Infarction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Swine; Xanthine Oxidase | 1996 |
Serial changes of the plasma prostanoids during myocardial ischemia-reperfusion in swine. Effects of magnesium, diltiazem, and a novel Mac-1 inhibitor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diltiazem; Enzyme-Linked Immunosorbent Assay; Female; Leucine; Macrophage-1 Antigen; Magnesium; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardial Stunning; Prostaglandins; Swine; Thromboxane B2 | 1997 |
Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 3. Hypotensive and antimyocardial-stunning effects in dogs.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Coronary Disease; Diltiazem; Dogs; Hemodynamics; Hypertension, Renal; In Vitro Techniques; Male; Myocardial Stunning; Vasodilation | 1997 |
Plasma fibronectin during myocardial ischemia-reperfusion: effects of magnesium, diltiazem, and a novel Mac-1 inhibitor.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diltiazem; Female; Fibronectins; Hemodynamics; Leucine; Macrophage-1 Antigen; Magnesium; Myocardial Reperfusion Injury; Myocardial Stunning; Swine; Time Factors | 1998 |
Serial changes of soluble endothelin-1 levels during myocardial ischaemia-reperfusion. Effects of magnesium, diltiazem and a novel MAC-1 inhibitor.
Topics: Animals; Diltiazem; Endothelin-1; Female; Leucine; Macrophage-1 Antigen; Magnesium; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Swine | 1998 |